作者
Giulia Sapuppo, Martina Tavarelli, Antonino Belfiore, Riccardo Vigneri, Gabriella Pellegriti
发表日期
2019/2
期刊
The Journal of Clinical Endocrinology & Metabolism
卷号
104
期号
2
页码范围
258-265
出版商
Endocrine Society
简介
Context
Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of patients with DTC have disease events after initial treatment, indistinctly defined as persistent/recurrent disease.
Objective
To evaluate the prevalence and outcome of “recurrent” disease (relapse after being 12 months disease-free) compared with “persistent” disease (present ab initio since diagnosis).
Design
Retrospective analysis of persistent/recurrent disease in patients with DTC (1990 to 2016) with 6.5 years of mean follow-up.
Setting
Tertiary referral center for thyroid cancer.
Patients
In total, 4292 patients all underwent surgery ± 131I treatment of DTC.
Main Outcome Measures
DTC cure of disease persistence or recurrence.
Results
A total of 639 of 4292 (14.9%) patients had …
学术搜索中的文章
G Sapuppo, M Tavarelli, A Belfiore, R Vigneri… - The Journal of Clinical Endocrinology & Metabolism, 2019